BUZZ-U.S. STOCKS ON THE MOVE-Transition Therapeutics, Celator, Meetme
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Wall Street was set to open lower on Wednesday after a setback in Greece's debt talks even as data showed that the U.S. economy's first-quarter contraction was smaller than earlier thought. Dow Jones industrial average futures were down 0.38 percent at 17,999, S&P 500 futures were down 0.24 percent at 2,111.5 and Nasdaq 100 futures were down 0.20 percent at 4,532.25.
** TRANSITION THERAPEUTICS INC, Tuesday close $9.09, -58.64 pct premarket
The drug developer said a mid-stage study of its experimental neuropshychiatric drug, ELND005, did not meet the main goal of significant reduction in agitation and aggression.
** CELATOR PHARMACEUTICALS INC, Tuesday close $2.24, +20.98 pct premarket
The drug developer said its experimental chemotherapy combination, CPX-351, showed relative improvement in response rate in patients with a form of blood cancer in a late-stage study.
** MEETME INC, Tuesday close $1.44, +25.69 pct premarket Continued...